When.com Web Search

  1. Ads

    related to: febuxostat for kidney failure patients list

Search results

  1. Results From The WOW.Com Content Network
  2. Febuxostat - Wikipedia

    en.wikipedia.org/wiki/Febuxostat

    Febuxostat, sold under the brand name Uloric among others, is a medication used long-term to treat gout due to high uric acid levels. [7] It is generally recommended only for people who cannot take allopurinol .

  3. Uricosuric - Wikipedia

    en.wikipedia.org/wiki/Uricosuric

    URAT1 is the central mediator in the transport of uric acid from the kidney into the blood. In some persons with loss-of-function mutations of URAT1, the uricosurics benzbromarone and losartan had no effect, suggesting these drugs act on URAT1 in vivo. [1] Thus, uricosuric drugs may be candidates for management in a personalized medicine model.

  4. Your Gout Guide: From Symptoms to Treatment - AOL

    www.aol.com/gout-guide-symptoms-treatment...

    Kidney disease. Obesity. Diabetes. High blood pressure. Heart disease. ... Febuxostat is another uric acid-lowering medication that may be used. Fascinadora / iStock. Gout Prevention Tips.

  5. Allopurinol - Wikipedia

    en.wikipedia.org/wiki/Allopurinol

    Allopurinol is used to reduce urate formation in conditions where urate deposition has already occurred or is predictable. The specific diseases and conditions where it is used include gouty arthritis, skin tophi, kidney stones, idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate ...

  6. Vadadustat - Wikipedia

    en.wikipedia.org/wiki/Vadadustat

    Vadadustat, sold under the brand name Vafseo, is a medication used for the treatment of symptomatic anemia associated with chronic kidney disease. [2] [3] Vadadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor. [2]

  7. US FDA approves CorMedix's drug for bloodstream infections - AOL

    www.aol.com/news/us-fda-approves-cormedixs...

    The drug was tested in a pool of 795 patients undergoing dialysis, where it showed a 71% reduction in the risk of occurrence of CRBSIs in kidney failure patients.

  1. Ads

    related to: febuxostat for kidney failure patients list